Skip to main navigation
Phio Pharmaceuticals

Phio Pharmaceuticals
  • Home
  • Company
    • Leadership
    • Career Opportunities
    • About
  • Focus
    • Cancer Immunotherapy
    • Our Approach
    • Pipeline
    • Collaboration
  • Technology
    • RNAi mechanism
    • Self-delivering RNAi
  • Investors
    • News Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors & Scientific Board
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Institutional Ownership
      • Annual Reports
      • Form 8937
    • Email Alerts
    • Contact Us

  • Home
  • Company
    • Leadership
    • Career Opportunities
    • About
  • Focus
    • Cancer Immunotherapy
    • Our Approach
    • Pipeline
    • Collaboration
  • Technology
    • RNAi mechanism
    • Self-delivering RNAi
  • Investors
    • News Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors & Scientific Board
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Institutional Ownership
      • Annual Reports
      • Form 8937
    • Email Alerts
    • Contact Us

Investor Relations

IR Contact

IR Contact

Investor Relations
ir@phiopharma.com

Business Development
James Cardia, Ph.D.
508-929-3634
jcardia@phiopharma.com 
 

  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • IR Contact
  • Share
2020 Terms | Privacy Policy
TOP